Luye Pharma Group Ltd. (HKG:2186)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.680
-0.130 (-3.41%)
Sep 10, 2025, 10:44 AM HKT

Luye Pharma Group Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
6,1686,0616,1435,9825,2005,540
Upgrade
Revenue Growth (YoY)
-2.31%-1.33%2.70%15.03%-6.13%-12.87%
Upgrade
Cost of Revenue
2,0452,0171,9391,8411,8031,549
Upgrade
Gross Profit
4,1234,0444,2044,1413,3973,991
Upgrade
Selling, General & Admin
2,5932,3982,7002,4032,2762,185
Upgrade
Other Operating Expenses
540.57509.26616.6948.82757.72816.86
Upgrade
Operating Expenses
3,1332,9083,3173,3513,0333,002
Upgrade
Operating Income
990.031,137887.44789.14363.4988.38
Upgrade
Interest Expense
-622.41-561.79-675.45-471.76-399.46-424
Upgrade
Interest & Investment Income
157.19157.19209.97176.1189.69151.05
Upgrade
Earnings From Equity Investments
-13.14-0.770.790.830.71.73
Upgrade
Currency Exchange Gain (Loss)
80.61-71.7346.03106.2-24.0949.75
Upgrade
Other Non Operating Income (Expenses)
177.36182.5241.77109.08129.65202.4
Upgrade
EBT Excluding Unusual Items
769.65841.98710.54709.59259.88969.31
Upgrade
Gain (Loss) on Sale of Investments
1.791.791.941.55-14.81-3.46
Upgrade
Gain (Loss) on Sale of Assets
18.4918.491.5-0.2111.360.09
Upgrade
Legal Settlements
-14.65-14.65-14.52-14.07-273.48-
Upgrade
Other Unusual Items
-8.39-8.390.63-27.09-57.51-23.76
Upgrade
Pretax Income
766.88839.22700.1669.76-74.56942.17
Upgrade
Income Tax Expense
202.67194.21161.0286.4770.23238.91
Upgrade
Earnings From Continuing Operations
564.21645.01539.08583.3-144.78703.27
Upgrade
Minority Interest in Earnings
-167.28-173.12-6.4721.5110.393.32
Upgrade
Net Income
396.94471.89532.61604.81-134.39706.59
Upgrade
Net Income to Common
396.94471.89532.61604.81-134.39706.59
Upgrade
Net Income Growth
-48.48%-11.40%-11.94%---49.39%
Upgrade
Shares Outstanding (Basic)
3,7623,7623,7283,4813,4453,187
Upgrade
Shares Outstanding (Diluted)
3,7623,7623,7283,4813,4453,194
Upgrade
Shares Change (YoY)
-0.01%0.89%7.11%1.03%7.87%-0.85%
Upgrade
EPS (Basic)
0.110.130.140.17-0.040.22
Upgrade
EPS (Diluted)
0.110.130.140.17-0.040.22
Upgrade
EPS Growth
-48.49%-12.22%-17.78%---48.96%
Upgrade
Free Cash Flow
--426.31962.83998.11-373.83340.64
Upgrade
Free Cash Flow Per Share
--0.110.260.29-0.110.11
Upgrade
Gross Margin
66.85%66.72%68.44%69.22%65.32%72.04%
Upgrade
Operating Margin
16.05%18.75%14.45%13.19%6.99%17.84%
Upgrade
Profit Margin
6.44%7.79%8.67%10.11%-2.58%12.75%
Upgrade
Free Cash Flow Margin
--7.03%15.67%16.69%-7.19%6.15%
Upgrade
EBITDA
1,7881,8921,5531,426906.881,467
Upgrade
EBITDA Margin
28.98%31.21%25.28%23.83%17.44%26.48%
Upgrade
D&A For EBITDA
797.56755665.47636.47543.48478.79
Upgrade
EBIT
990.031,137887.44789.14363.4988.38
Upgrade
EBIT Margin
16.05%18.75%14.45%13.19%6.99%17.84%
Upgrade
Effective Tax Rate
26.43%23.14%23.00%12.91%-25.36%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.